Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Concentrations of Long Acting Morphine After Oral Absorption in Subjects Who Underwent Gastric Bypass (OBEMO 2)

NCT02641301 is registered in ClinicalTrials.gov with Hopital Lariboisière as lead sponsor.

NCT NCT02641301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02641301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Concentrations of Long Acting Morphine After Oral Absorption in Subjects Who Underwent Gastric Bypass (OBEMO 2)
Lead sponsor
Hopital Lariboisière
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2015
Completion date
March 31, 2017
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bypass complications